GlassScriptPhysician profile
Syed Samar Raza
NPI 1285734715
$45,158.73
in general payments reported to CMS, 2019-2025
11 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $3,226 · 2021: $25K · 2022: $13K · 2023: $3,035 · 2024: $158 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,550 · Food and Beverage: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,550.00 |
| Food and Beverage | $924.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $44,420.51 | 2019-2023 | Lokelma |
| Acadia Pharmaceuticals INC | $128.15 | 2020-2023 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $125.48 | 2025 | Ultomiris |
| Otsuka America Pharmaceutical, INC. | $123.23 | 2023 | Nuedexta |
| Artivion, INC. | $117.94 | 2025 | Cryovalve Sg Pulmonary Human Heart Valve, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Janssen Pharmaceuticals, INC | $65.63 | 2023-2024 | Xarelto |
| Atricure, INC. | $62.15 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.03 | 2025 | Lifevest |
| Mallinckrodt Hospital Products INC. | $34.10 | 2024 | Terlivaz |
| Teva Pharmaceuticals USA, INC. | $22.43 | 2024 | Austedo Xr |
| Smith+Nephew, INC. | $20.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Samar Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.